| 16729-092 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | ANDA | Current |
| 16729-092 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | ANDA | Current |
| 16729-092 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | ANDA | Current |
| 16729-117 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | ANDA | Current |
| 16729-117 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | ANDA | Current |
| 16729-117 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | ANDA | Current |
| 16729-118 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | ANDA | Current |
| 16729-118 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | ANDA | Current |
| 16729-118 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | ANDA | Current |
| 68001-282 | Gemcitabine Hydrochloride | Gemcitabine Hydrochloride | BluePoint Laboratories | ANDA | Current |
| 68001-282 | Gemcitabine Hydrochloride | Gemcitabine Hydrochloride | BluePoint Laboratories | ANDA | Current |